|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/155 | (2006.01) |
| (11) | Number of the document | 2370099 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09836751.9 |
| Date of filing the European patent application | 2009-12-09 | |
| (97) | Date of publication of the European application | 2011-10-05 |
| (45) | Date of publication and mention of the grant of the patent | 2016-04-20 |
| (46) | Date of publication of the claims translation | 2016-08-10 |
| (86) | Number | PCT/US2009/067269 |
| Date | 2009-12-09 |
| (87) | Number | WO 2010/077717 |
| Date | 2010-07-08 |
| (30) | Number | Date | Country code |
| 121126 P | 2008-12-09 | US | |
| 169077 P | 2009-04-14 | US | |
| 224787 P | 2009-07-10 | US |
| (72) |
PUSHKO, Peter, US
WU, Yingyun, US
MASSARE, Michael, US
LIU, Ye, US
SMITH, Gale, US
ZHOU, Bin, US
|
| (73) |
Novavax, Inc.,
9920 Belward Campus Drive, Rockville, MD 20850,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Modifikuoti RSV F baltymai ir jų panaudojimo būdai |
| MODIFIED RSV F PROTEINS AND METHODS OF THEIR USE |
| Payment date | Validity (years) | Amount | |
| 2024-11-19 | 16 | 347.00 EUR |
| 2025-12-09 |